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Abstract: Clinical guidelines for the treatment of depression and anxiety 
recommend psychological interventions organised in a stepped care model, 
where patients initially access low intensity guided self-help followed by high 
intensity psychotherapies if their symptoms persist. The Leeds Risk Index 
(LRI) is a data-driven tool that enables clinicians to profile patients into 
subgroups with low, moderate or high risk of poor response to treatment. A 
prior retrospective analysis of routine care data suggested that clinical 
outcomes for high risk cases could be improved by directly assigning them to 
high intensity treatments (stratified care) rather than usual stepped care. 
This study was the first prospective field-test of a stratified treatment 
selection approach based on the LRI tool. Post-treatment depression (PHQ-9) 
and anxiety (GAD-7) remission rates, dropout rates and treatment duration 
were compared between 157 stratified care cases vs. 125 stepped care 
controls. The results indicate that stratified care significantly improved the 
efficiency of psychological treatment, attaining comparable clinical outcomes 
in a shorter overall treatment duration. 
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Clinical guidelines for the treatment of depression and anxiety 
problems recommend evidence-based psychological interventions organised 
in a stepped care model, where patients initially access low intensity self-
help interventions guided by qualified practitioners and later have the option 
to access high intensity psychological therapies if their symptoms persist [1]. 
Stepped care services are widely available in England and have been shown 
to be effective, although it is also recognised that around half of patients who 
access treatment do not attain remission of symptoms [2]. Even if they 
present with similar symptoms (e.g., depression), patients accessing stepped 
care services are heterogeneous in other important features such as age, 
employment, disability, functional impairment, symptom severity and 
expectations about the benefits of therapy. A recent study found that the 
above patient-features were significantly associated with post-treatment 
remission of symptoms [3]. Using the regression weights for each of these 
features, the authors developed the Leeds Risk Index (LRI), a simple tool that 
enables clinicians to profile patients into subgroups with low, moderate or 
high risk of poor response to psychological treatment (Figure 1 ² panel A). 
Applying the LRI profiling tool in a retrospective analysis of data from 1347 
patients, the authors found that high risk cases tended to have significantly 
higher remission rates after high intensity therapies by comparison to low 
intensity guided self-help. On this basis, they proposed that a stratified care 
approach matching high risk cases directly to high intensity therapies could 
be more cost-effective than stepped care. 
The present study was a prospective field-test of the LRI stratified care 
approach. A team of 12 qualified psychological therapists working in an 
English stepped care service co-designed a decision algorithm (Figure 1 ² 
panel B) that would enable them to use the LRI tool for psychological 
treatment selection in a way that is compatible with clinical guidelines [1] 
which require that cases with certain conditions (e.g., post-traumatic stress 
disorder) should be directly assigned to high intensity therapies. They 
applied this decision algorithm to make treatment recommendations for all 
patients who they consecutively assessed during a 3-month period (N=157). 
All patients completed the PHQ-9 depression [4] and GAD-7 anxiety [5] 
measures on a session-to-session basis, following routine outcome 
monitoring guidelines [2]. The study sample was matched to a sample of 125 
control cases from archival clinical records, who had similar baseline 
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characteristics (LRI profiles) and who accessed routine stepped care. Case-
control matching was achieved using a propensity score matching method 
[6]. We then compared post-treatment reliable and clinically significant 
improvement (RCSI) rates [3], dropout rates and treatment duration between 
LRI study cases and matched controls. Statistical analyses included chi-
square tests for binary variables, non-parametric comparison of means, and 
logistic regression to examine LRI profile x treatment interactions. The 
primary outcome measure was the PHQ-9. 
The LRI study sample included mostly females (72.0%), from a white 
British background (90.2%), with an average age of 34.9 (SD=14.66), of 
whom 42.1% were unemployed. Mean baseline severity measures were: 
PHQ-9=15.12 (SD=5.21); GAD-7=13.52 (SD=4.44). Approximately 50.0% had 
an affective disorder, 34.7% had generalized anxiety disorder, 4.8% had 
panic disorder, and other conditions were less prevalent. According to the 
LRI, 28.5% were classified as low risk, 56.1% as moderate risk, and 15.4% as 
high risk cases. There were no significant differences between study cases 
and controls in any of the baseline severity measures or LRI classification. 
There were significant differences in the treatment pathway of LRI 
cases versus controls (x2[DF 2]=11.95, p<.01). Both groups had a similar 
proportion of cases that only accessed low intensity treatment (cases=67.2%; 
controls=64.8%). However, a higher number of LRI study cases were fast-
tracked to high intensity treatments (24.8% vs. 13.6%), and a lower number 
of LRI study cases had combined low + high intensity treatments (8% vs. 
21.6%). This meant that including the LRI in treatment selection decisions 
approximately led to an 11% increase in direct allocation to high-intensity 
treatments. 
There were no significant differences in symptom remission (RCSI) 
rates between cases (45.0%) vs. controls (45.4%) in the full sample (x2[DF 
1]=0.003, p=.96). High risk cases had considerably higher depression 
remission rates in the LRI study sample vs. controls (38.9% vs. 18.8%); 
however, the interaction term in logistic regression was not statistically 
significant (Odds Ratio=3.27, p=.17). These findings were consistent in the 
PHQ-9 and GAD-7 measures. There were significant differences in treatment 
duration, measured in mean number of weeks between initial assessment 
and discharge dates (21.03 vs. 28.26). Treatment duration for LRI study 
cases was approximately 7 weeks shorter than controls (U[250]=6144.50, 
4 
 
p<.01). These differences were unrelated to dropout, since there were no 
significant differences in dropout rates (~34.2%) between study cases and 
controls [x2 (DF 1)=0.29, p<.59]. 
Overall, LRI study cases had similar clinical outcomes attained within 
a shorter treatment episode and this was unrelated to dropout. These 
findings indicate that stratified treatment selection reduces the number of 
cases that have an unnecessary ´GRXEOH GRVHµ RI WUHDWPHQW low + high 
intensity). High risk cases tended to have higher remission rates in the LRI 
study sample, although this interaction effect was not statistically 
significant. One explanation might be that this apparent interaction effect is 
simply due to chance, although it shows the same symptom response 
pattern observed in a previous study [3]. An alternative explanation is that 
the present sample was too small to detect the observed moderate effect size 
(OR=3.27), since this effect is only relevant to a subsample of high risk cases 
(15% of the total sample).  
To our knowledge, this is the first prospective field-test of a data-
driven and stratified approach to psychological treatment selection, 
representing an important landmark for the emerging field of precision 
mental healthcare. However, some important limitations should be 
considered. The study dataset did not include therapist identifiers, so it was 
not possible to control for potential therapist effects. Furthermore, we 
applied propensity score matching to derive comparable groups in a quasi-
experimental design, but this does not rule out the possibility that 
unmeasured confounders could be unbalanced across groups. Large 
randomised controlled trials are necessary to verify the apparent clinical 
advantages of matching high risk cases to high intensity treatments, 
although the current evidence convincingly shows that stratified care 
improves the efficiency of treatment. 
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Figure 1. A patient profiling and stratified treatment selection model 
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